Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 11—November 2005

Neutralizing Antibody Response and SARS Severity

Mei-Shang Ho*, Wei-Ju Chen*, Hour-Young Chen†, Szu-Fong Lin†, Min-Chin Wang†, Jiali Di†, Yen-Ta Lu‡, Ching-Lung Liu‡, Shan-Chwen Chang§, Chung-Liang Chao¶, Chwan-Chuen King§, Jeng-Min Chiou*, Ih-Jen Su#, and Jyh-Yuan Yang†Comments to Author 
Author affiliations: *Academia Sinica, Taipei, Taiwan; †Center for Disease Control, Taipei, Taiwan; ‡Taipei Mackay Memorial Hospital, Taipei, Taiwan; §National Taiwan University, Taipei, Taiwan; ¶Taipei Hospital, Taipei, Taiwan; #National Health Research Institutes, Taipei, Taiwan

Main Article

Table 6

Comparison of early seroresponders and other SARS patients, by death rate, time of death, and age*

Factor Early seroresponders†
OR p value‡
Yes, n (%) No, n (%)
Yes 29.6 (8) 7.8 (10) 4.97 0.004
No 70.4 (19) 92.2 (118) 1.00
Died within 2 wk
Yes 75.0 (6) 10.0 (1) 0.013
No 25.0 (2) 90.0 (9)
Age (y)
>60 (n = 14) 42.9 (6) 57.1 (8) 0.01
<60 (n = 141) 14.9 (21) 85.1 (120)

*SARS, severe acute respiratory syndrome; OR, odds ratio.
†Early seroresponders are SARS patients who were seropositive for SARS neutralizing antibody during the first 2 weeks of illness.
‡p value based on Fisher exact test.

Main Article

Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.